Cosmic Stocks

[ProfitScout]

$CURR has buying volume coming in regularly now supporting a newly started uptrend. With many positive developments in the company's news so far in 2022 it is not hard to justify the accumulation going on. The upside potential for CURR is high, especially to investors who have a little patience.

About CURE Pharmaceutical

CURE Pharmaceutical is the pioneering developer of CUREform(TM), a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. Among CURE's key products is its oral thin film, 40,000 IU dose Vitamin D, (Branded Nutri-Strips(TM) in the Retail Market). Each strip is hermetically sealed in airtight, grab-and-go packaging to eliminate chemical and structural breakdown and provide superior potency. Nutri-Strips(TM) are available online at https://www.nutristripnow.com/immund3

As a vertically integrated company, CURE's 25,000 square foot, FDA-registered, NSF and cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.
http://www.curepharma.com